title: Antibiotic-induced oligomerisation of group I intron RNA.
abstract: Antibiotics act as inhibitors of various biological processes. Here we demonstrate that some tuberactinomycins, hitherto known as inhibitors of prokaryotic protein synthesis and of group I intron self-splicing, have a modulatory effect on group I intron RNAs. The linear intron, which is excised during the self-splicing process, is still an active molecular capable of performing an intramolecular transesterification resulting in a circular molecule. However, in the presence of sub-inhibitory concentrations of tuberactinomycins, the intron reacts intermolecularly leading to the formation of linear head-to-tail intron-oligomers. The antibiotic stimulates the intron to react in trans instead of in cis. The phage T4-derived td intron uses the same sites for oligomerisation as for circularisation. Gel- retardation experiments demonstrate that the intron RNA forms non-covalent complexes in the presence of the antibiotic. It might be envisaged that the role of these peptide antibiotics is to bridge RNA molecules mediating RNA-RNA interactions and thus enabling their reaction. The tuberactinomycins are further able to induce the interaction of heterologous introns. The ligation of the T4 phage-derived td intron with the Tetrahymena rRNA intron is very efficient, resulting in molecules composed of two introns derived from different species. The td intron attacks the Tetrahymena intron at various sites, which are located within double-stranded regions. These observations suggest that small molecules like these basic peptide antibiotics could have mediated RNA-RNA interactions in a pre-protein era.
authors.affiliation: Institute of Microbiology and Genetics, University of Vienna, Vienna Biocenter, Austria.
authors.forename: H
authors.initials: H
authors.lastname: Wank
authors.forename: R
authors.initials: R
authors.lastname: Schroeder
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D017122:Bacteriophage T4 / Q000737:chemistry; D001483:Base Sequence; D004776:Enviomycin / Q000031:analogs & derivatives / Q000494:pharmacology; D007438:Introns / Q000187:drug effects*; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation / Q000187:drug effects*; D012313:RNA / Q000737:chemistry; D012326:RNA Splicing / Q000187:drug effects; D016337:RNA, Catalytic / Q000737:chemistry / Q000187:drug effects*; D000079962:RNA, Circular; D016053:RNA, Protozoan / Q000737:chemistry; D012335:RNA, Ribosomal / Q000737:chemistry; D012367:RNA, Viral / Q000737:chemistry; D017422:Sequence Analysis, DNA; D016808:Tetrahymena thermophila / Q000737:chemistry; D014756:Viomycin / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D016337:RNA, Catalytic; D000079962:RNA, Circular; D016053:RNA, Protozoan; D012335:RNA, Ribosomal; D012367:RNA, Viral; D012313:RNA; C015563:tuberactinomycin; D004776:Enviomycin; D014756:Viomycin